Gurevičienė, G. “PD-L1 INHIBITOR ATEZOLIZUMAB▼ - FOR NSCLC TREATMENT AFTER PRIOR CHEMOTHERAPY”. Pulmonology and Allergology, Vol. 3, no. 1, Sept. 2020, pp. 102-8, doi:10.37499/PIA.154.